A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

Volume: 109, Issue: 8
Published: Aug 1, 2017
Abstract
Background Blood-based biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) are urgently needed. Current biomarkers lack high sensitivity and specificity for population screening. The gold-standard biomarker, CA 19-9, also fails to demonstrate the predictive value necessary for early detection. Methods To validate a functional genomics-based plasma migration signature biomarker panel, plasma tissue factor pathway inhibitor...
Paper Details
Title
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
Published Date
Aug 1, 2017
Volume
109
Issue
8
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.